Document is current

Article History

Received: 28 October 2018

Accepted: 11 January 2019

First Online: 7 February 2019

Ethics approval and consent to participate

: The study was approved by the University of Sydney Human Research Ethics Committee (Approval Number: 2017/096), and online written informed consent was obtained from all participants.

: Not applicable.

: AIH has no competing interests.PH receives/has received sessional fees and lecture fees from the Australian Medical Council, Therapeutic Guidelines publication, and HETI New South Wales and royalties/honoraria from Hogrefe and Huber, McGraw Hill Education, and Blackwell Scientific Publications, Biomed Central and PlosMedicine and she has received research grants from the NHMRC and ARC. She is Deputy Chair of the Steering Committee of the National Eating Disorders Collaboration in Australia (2012-) and Member of the ICD-11 Working Group for Eating Disorders (2012-) and was Chair Clinical Practice Guidelines Project Working Group (Eating Disorders) of RANZCP (2012–2015). In July 2017, she provided a commissioned report for Shire Pharmaceuticals on lisdexamfetamine and binge eating disorder (BED) and has received funding form Shire to attend and present at meetings on BED. She is Editor-in-Chief of Journal of Eating Disorders.ST has received royalties from Hogrefe and Huber, McGraw Hill Education and Routledge for the publication of books/chapters. He is the Chair of the Shire (Australian) BED Advisory Committee and has provided commissioned reports, received travel grants, grant funding, travel grants and honoraria from Shire Pharmaceuticals, and is a consultant to WW International. He is Editor-in-Chief of Journal of Eating Disorders.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.